2 FTSE growth stocks to buy as the US market becomes almost uninvestible!

For me, the current exchange rate makes long-term investments in the US a no-go. That’s why I’m looking at these two FTSE stocks for growth.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

A GlaxoSmithKline scientist uses a microscope

Image: GlaxoSmithKline

There’s a couple of reasons why I favour the FTSE over any other index right now. One of them is valuations. UK-listed stocks just haven’t been that popular amid concerns about the general health of the economy and Brexit.

But now there’s the exchange rate to think about. A year ago, £1 got me around $1.40. But the pound has got weaker and the dollar stronger. Today, £1 gets me $1.20, and some analysts think the pound may drop over the next couple of weeks to $1.15.

So, why is the exchange rate important? In the long run, I foresee the pound being a stronger position than it is now. If I invested in a US stock now, and the pound appreciated 10% over the next three years, then it would wipe 10% off the value of my investment.

As a result, I’m looking at UK-listed growth stocks instead of the NASDAQ. So, here are two of my top UK growth stocks I’d buy now.

Kropz

Kropz (LSE:KRPZ) is an Africa-focused phosphate rock mining company. Rock phosphate is the raw material that’s used to produce phosphate fertilisers. The company is looking to play a major role in the food industry in the decades to come. 

The company’s main asset is in Elandsfontein, South Africa’s Western Cape province. Kropz hopes to produce rock phosphate from its Elandsfontein mine later this year. However, it has already been forced to delayed its first bulk sale, which is now forecast later this year.

Around 85% rock phosphate is used in fertiliser production. And it might not be a bad time to be entering the market as fertiliser prices have gone sky-high on the back of higher fuel prices.

Kropz also says that the Hinda rock phosphate asset in Republic of Congo could be “one of the world’s largest undeveloped sedimentary-hosted phosphate reserves“.

I’m a little concerned about when first production will be. And it’s worth noting that there’s a sizeable spread between the buying and selling price. Nevertheless, I see this stock as a good long-term investment.

Ceres Power

Ceres Power (LSE:CWR) is a fuel cell and electrochemical technology developer. There is clearly a lot of potential for any player in this area.

The company has been moving fairly slowly, but there are signs this stock might be about to take off. The AIM-traded firm recently announced that the completion of a China-focused joint venture with Bosch and Weichai Power was now expected to take place in the second half of the year.

Fuel cells won’t only be used in cars, but everything from powering homes to supporting massive cloud data centres. In partnership with Weichai, Ceres has developed a unique electric vehicle (EV) range extender system, using its SteelCell product, delivering high levels of efficiency and with very low emissions.

In June, Ceres Power also announced the signing of an agreement with Shell to deliver a megawatt-scale solid oxide electrolyser demonstrator in 2023. It will be used at Shell’s research and development technology centre in Bangalore where the hydrogen will be used in industrial processes on site. Such products could have huge potential in remote facilities or construction sites, such as Saudi’s NEOM project.

James Fox has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »